HemaSphere
(Jan 2021)
CCND1 Genomic Rearrangement as a Secondary Event in High Grade B-Cell Lymphoma
- Jinjun Cheng,
- Mohamed Amin Hashem,
- Frederic Barabé,
- Stéphanie Cloutier,
- Liqiang Xi,
- Mark Raffeld,
- Stefania Pittaluga,
- Elaine S. Jaffe
Affiliations
- Jinjun Cheng
- 1 Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
- Mohamed Amin Hashem
- 2 Service d’Anatomopathologie et Cytologie, CHU de Québec, Université Laval, Quebec, Canada
- Frederic Barabé
- 3 Department of Medicine, CHU de Québec, Université Laval, Quebec, Canada.
- Stéphanie Cloutier
- 3 Department of Medicine, CHU de Québec, Université Laval, Quebec, Canada.
- Liqiang Xi
- 1 Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
- Mark Raffeld
- 1 Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
- Stefania Pittaluga
- 1 Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
- Elaine S. Jaffe
- 1 Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
- DOI
-
https://doi.org/10.1097/HS9.0000000000000505
- Journal volume & issue
-
Vol. 5,
no. 1
p.
e505
WeChat QR code